Sigrid Spandl-Machherndl

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Chromosome 1q alterations in transplant-eligible multiple myeloma: clinical impact of copy number and co-occurring high-risk cytogenetic features.

Chromosome 1q alterations in transplant-eligible multiple myeloma: clinical impact of copy number and co-occurring high-risk cytogenetic features.

Journal: Frontiers in oncology

Published: May 31, 2026

Long-term follow-up of ruxolitinib pre-approval use in acute and chronic graft-versus-host disease.

Long-term follow-up of ruxolitinib pre-approval use in acute and chronic graft-versus-host disease.

Journal: Annals of hematology

Published: May 28, 2026

Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma.

Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma.

Journal: Transplantation and cellular therapy

Published: April 25, 2026

Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.

Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.

Journal: British journal of haematology

Published: April 25, 2026

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Journal: Blood cancer journal

Published: December 19, 2025

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Journal: Cancers

Published: October 18, 2025

The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis.

The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis.

Journal: Cell transplantation

Published: August 14, 2025

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Journal: Blood cancer journal

Published: June 17, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.

Journal: Journal of clinical medicine

Published: March 16, 2025

Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.

Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 11, 2024

Successful termination of a multi-year wastewater-associated outbreak of NDM-5-carrying E. coli in a hemato-oncological center.

Successful termination of a multi-year wastewater-associated outbreak of NDM-5-carrying E. coli in a hemato-oncological center.

Journal: Antimicrobial resistance and infection control

Published: October 04, 2024

Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

Journal: Cytotherapy

Published: September 15, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026